Neuphoria Therapeutics (NEUP) Intangibles (2020 - 2026)

Neuphoria Therapeutics (NEUP) has reported Intangibles for 7 consecutive years, with $4.3 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Intangibles fell 13.33% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 13.33% decrease from a year earlier, with the FY2025 full-year figure at $4.8 million, down 12.12% from the prior year.
• Intangibles was $4.3 million for Q1 2026 at Neuphoria Therapeutics, down from $4.5 million in the prior quarter.
• Over five years, Intangibles peaked at $7.0 million in Q2 2022 and troughed at $4.3 million in Q1 2026.
• A 5-year average of $5.4 million and a median of $5.3 million in 2024 frame the typical range for Intangibles.
• Across the five-year window, Intangibles decreased 7.99% in 2022 and decreased 13.33% in 2026, its largest moves.
• Over 5 years, Intangibles stood at $7.0 million in 2022, then decreased by 17.71% to $5.8 million in 2023, then declined by 11.43% to $5.1 million in 2024, then fell by 12.9% to $4.5 million in 2025, then fell by 3.7% to $4.3 million in 2026.
• The last three Intangibles figures came in at $4.3 million (Q1 2026), $4.5 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.